These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34281467)

  • 21. Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program.
    Perreault L; Kahn SE; Christophi CA; Knowler WC; Hamman RF;
    Diabetes Care; 2009 Sep; 32(9):1583-8. PubMed ID: 19587364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors affecting the decline in incidence of diabetes in the Diabetes Prevention Program Outcomes Study (DPPOS).
    ; Hamman RF; Horton E; Barrett-Connor E; Bray GA; Christophi CA; Crandall J; Florez JC; Fowler S; Goldberg R; Kahn SE; Knowler WC; Lachin JM; Murphy MB; Venditti E
    Diabetes; 2015 Mar; 64(3):989-98. PubMed ID: 25277389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Lifestyle and Metformin Interventions on the Risk of Progression to Diabetes and Regression to Normal Glucose Regulation in Overweight or Obese People With Impaired Glucose Regulation.
    Herman WH; Pan Q; Edelstein SL; Mather KJ; Perreault L; Barrett-Connor E; Dabelea DM; Horton E; Kahn SE; Knowler WC; Lorenzo C; Pi-Sunyer X; Venditti E; Ye W;
    Diabetes Care; 2017 Dec; 40(12):1668-1677. PubMed ID: 29021207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating the cost-effectiveness of lifestyle modification versus metformin therapy for the prevention of diabetes in Singapore.
    Png ME; Yoong JS
    PLoS One; 2014; 9(9):e107225. PubMed ID: 25203633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-Term Weight Loss With Metformin or Lifestyle Intervention in the Diabetes Prevention Program Outcomes Study.
    Apolzan JW; Venditti EM; Edelstein SL; Knowler WC; Dabelea D; Boyko EJ; Pi-Sunyer X; Kalyani RR; Franks PW; Srikanthan P; Gadde KM;
    Ann Intern Med; 2019 May; 170(10):682-690. PubMed ID: 31009939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral anti-diabetic agents for women with established diabetes/impaired glucose tolerance or previous gestational diabetes planning pregnancy, or pregnant women with pre-existing diabetes.
    Tieu J; Coat S; Hague W; Middleton P; Shepherd E
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD007724. PubMed ID: 29045765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of Shared Decision-making for Diabetes Prevention: 12-Month Results from the Prediabetes Informed Decision and Education (PRIDE) Trial.
    Moin T; Duru OK; Turk N; Chon JS; Frosch DL; Martin JM; Jeffers KS; Castellon-Lopez Y; Tseng CH; Norris K; Mangione CM
    J Gen Intern Med; 2019 Nov; 34(11):2652-2659. PubMed ID: 31471729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does diabetes prevention translate into reduced long-term vascular complications of diabetes?
    Nathan DM; Bennett PH; Crandall JP; Edelstein SL; Goldberg RB; Kahn SE; Knowler WC; Mather KJ; Mudaliar S; Orchard TJ; Temprosa M; White NH;
    Diabetologia; 2019 Aug; 62(8):1319-1328. PubMed ID: 31270584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention.
    Hostalek U; Gwilt M; Hildemann S
    Drugs; 2015 Jul; 75(10):1071-94. PubMed ID: 26059289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacotherapeutic options for prediabetes.
    Rendell M
    Expert Opin Pharmacother; 2021 Jan; 22(1):45-54. PubMed ID: 32892663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The combination of linagliptin, metformin and lifestyle modification to prevent type 2 diabetes (PRELLIM). A randomized clinical trial.
    Guardado-Mendoza R; Salazar-López SS; Álvarez-Canales M; Farfán-Vázquez D; Martínez-López YE; Jiménez-Ceja LM; Suárez-Pérez EL; Angulo-Romero F; Evia-Viscarra ML; Montes de Oca-Loyola ML; Durán-Pérez EG; Folli F; Aguilar-García A
    Metabolism; 2020 Mar; 104():154054. PubMed ID: 31887309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PREVENT-DM Comparative Effectiveness Trial of Lifestyle Intervention and Metformin.
    O'Brien MJ; Perez A; Scanlan AB; Alos VA; Whitaker RC; Foster GD; Ackermann RT; Ciolino JD; Homko C
    Am J Prev Med; 2017 Jun; 52(6):788-797. PubMed ID: 28237635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin Should Not Be Used to Treat Prediabetes.
    Davidson MB
    Diabetes Care; 2020 Sep; 43(9):1983-1987. PubMed ID: 32936780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up.
    Aroda VR; Christophi CA; Edelstein SL; Zhang P; Herman WH; Barrett-Connor E; Delahanty LM; Montez MG; Ackermann RT; Zhuo X; Knowler WC; Ratner RE;
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1646-53. PubMed ID: 25706240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic risk of progression to type 2 diabetes and response to intensive lifestyle or metformin in prediabetic women with and without a history of gestational diabetes mellitus.
    Sullivan SD; Jablonski KA; Florez JC; Dabelea D; Franks PW; Dagogo-Jack S; Kim C; Knowler WC; Christophi CA; Ratner R;
    Diabetes Care; 2014 Apr; 37(4):909-11. PubMed ID: 24271189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term metformin adherence in the Diabetes Prevention Program Outcomes Study.
    Walker EA; Gonzalez JS; Tripputi MT; Dagogo-Jack S; Matulik MJ; Montez MG; Tadros S; Edelstein SL;
    BMJ Open Diabetes Res Care; 2020 Oct; 8(1):. PubMed ID: 33023898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological strategies for preventing type 2 diabetes in patients with impaired glucose tolerance.
    Smith-Marsh D
    Drugs Today (Barc); 2013 Aug; 49(8):499-507. PubMed ID: 23977667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of type 2 diabetes in the prediabetic population.
    Maji D; Roy RU; Das S
    J Indian Med Assoc; 2005 Nov; 103(11):609-11. PubMed ID: 16570766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Network Meta-analysis of the Therapeutic Effects of Hypoglycemic Drugs and Intensive Lifestyle Modification on Impaired Glucose Tolerance.
    Zhang Y; Fu Y; Mu YM; Huang Y; Xuan J
    Clin Ther; 2021 Sep; 43(9):1524-1556. PubMed ID: 34452739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.